Novo Integrated Sciences Stock Working Capital
| NVOSDelisted Stock | USD 0.04 0.01 17.57% |
Novo Integrated Sciences fundamentals help investors to digest information that contributes to Novo Integrated's financial success or failures. It also enables traders to predict the movement of Novo OTC Stock. The fundamental analysis module provides a way to measure Novo Integrated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novo Integrated otc stock.
Novo |
Novo Integrated Sciences OTC Stock Working Capital Analysis
Novo Integrated's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Novo Integrated Working Capital | (3.52 M) |
Most of Novo Integrated's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novo Integrated Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, Novo Integrated Sciences has a Working Capital of (3.52 Million). This is 100.83% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is 100.24% higher than that of the company.
Novo Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novo Integrated's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Novo Integrated could also be used in its relative valuation, which is a method of valuing Novo Integrated by comparing valuation metrics of similar companies.Novo Integrated is currently under evaluation in working capital category among its peers.
Novo Fundamentals
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (1.80) % | ||||
| Operating Margin | (0.80) % | ||||
| Current Valuation | 5.8 M | ||||
| Shares Outstanding | 19.05 M | ||||
| Shares Owned By Insiders | 6.82 % | ||||
| Shares Owned By Institutions | 5.77 % | ||||
| Number Of Shares Shorted | 274.86 K | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 12.57 M | ||||
| Gross Profit | 3.82 M | ||||
| EBITDA | (5.63 M) | ||||
| Net Income | (13.27 M) | ||||
| Cash And Equivalents | 12.68 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 4.47 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.52 X | ||||
| Cash Flow From Operations | (2.24 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (0.41) X | ||||
| Number Of Employees | 127 | ||||
| Beta | -0.69 | ||||
| Market Capitalization | 2.84 M | ||||
| Total Asset | 35.56 M | ||||
| Retained Earnings | (67.03 M) | ||||
| Working Capital | (3.52 M) | ||||
| Net Asset | 35.56 M |
About Novo Integrated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novo Integrated Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novo Integrated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novo Integrated Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Integrated Sciences. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Novo OTC Stock
If you are still planning to invest in Novo Integrated Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novo Integrated's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |